WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012044825) CRYSTALLINE OXALATE SALTS OF A DIAMIDE COMPOUND
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/044825    International Application No.:    PCT/US2011/053997
Publication Date: 05.04.2012 International Filing Date: 29.09.2011
IPC:
C07D 401/12 (2006.01), A61K 31/444 (2006.01), A61P 11/08 (2006.01)
Applicants: THERAVANCE, INC. [US/US]; 901 Gateway Boulevard South San Francisco, California 94080 (US) (For All Designated States Except US).
RAPTA, Miroslav [SK/US]; (US) (For US Only).
THALLADI, Venkat [IN/US]; (US) (For US Only).
CHAO, Robert [US/US]; (US) (For US Only)
Inventors: RAPTA, Miroslav; (US).
THALLADI, Venkat; (US).
CHAO, Robert; (US)
Agent: HAGENAH, Jeffrey, A.; Theravance, Inc. 901 Gateway Boulevard South San Francisco, California 94080 (US)
Priority Data:
61/388,148 30.09.2010 US
Title (EN) CRYSTALLINE OXALATE SALTS OF A DIAMIDE COMPOUND
(FR) SELS D'OXALATE CRISTALLINS D'UN DIAMIDE
Abstract: front page image
(EN)The invention relates to crystalline oxalate salts of biphenyl-2-ylcarbamic acid 1-(2-{[4-(4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-l,2-dihydroquinolin-5-yl)ethylamino]-methyl}phenylcarbamoyl)butyl]methylcarbamoyl}ethyl)piperidin-4-yl ester. This invention also relates to compositions containing such a crystalline oxalate salt; methods of using such a crystalline oxalate salt to, for example, treat a pulmonary disorder; and to processes for preparing such a crystalline oxalate salt.
(FR)La présente invention concerne des sels d'oxalate cristallins de biphényl-2-ylcarbamate de 1-(2-{[4-(4-{[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinoléin-5-yl)éthylamino]-méthyl}phénylcarbamoyl)butyl]méthylcarbamoyl}éthyl)-[pipéridin-4-yle. La présente invention concerne également des compositions contenant un tel sel d'oxalate cristallin ; des méthodes d'utilisation d'un tel sel d'oxalate cristallin, par exemple dans le traitement d'un trouble pulmonaire ; et des procédés de synthèse d'un tel sel d'oxalate cristallin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)